The effects of swimming exercise on high-fat-diet-induced steatohepatitis

Journal of Sports Medicine and Physical Fitness

Volumn 48, Issue 2, 2008, Pages 259-265

  He, Y ^a   Zhang, H ^a   Fu, F H ^b  

^a HEBEI NORMAL UNIVERSITY   (China)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Diet; Fatty liver; Liver diseases; Steatonecrosis; Swimming

Indexed keywords

ANIMAL; ARTICLE; FAT INTAKE; FATTY LIVER; MALE; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; SWIMMING;

ANIMALS; DIETARY FATS; FATTY LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; SWIMMING;

EID: 46349104762     PISSN: 00224707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003:37:1202-19.
2. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002; 122:1649-57.
3. Clark JM, Brancati FL. Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003:98:960-7.
4. Marchesini G. Forlani G. NASH: from liver diseases to metabolic disorders and back to clinical hepatology. Hepatology 2002;35:497-9.
5. Marchesini G. Bugianesi E. Forlani G. Cerrelli F, Lenzi M. Manini R et al. Nonalcoholic fatty liver, steatohepatitis. and the metabolic syndrome. Hepatology 2003:37:917-23.
6. James OF. Day CP. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol 1998:29:495-501.
7. Kugelmas M. Hill DB, Vivian B, Marsano L. McClain CJ. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology 2003;38:413-9.
8. Jansen PL. Nonalcoholic steatohepatitis. Neth J Med 2004;62:217-24.
9. Gauthier MS. Couturier K. Latour JG, Lavoie JM. Concurrent exercise prevents high-fat-diet-induced macrovesicular hepatic steatosis. J Appl Physiol 2003;94:2127-34.
10. Gauthier MS, Couturier K, Charbonneau A. Lavoie JM. Effects of introducing physical training in the course of a 16-week high-fat diet regimen on hepatic steatosis, adipose tissue fat accumulation, and plasma lipid profile. Int J Obes Relat Metab Disord 2004;28:1064-71.
11. Angulo P. Nonalcoholic fatty liver disease. N Enal J Med 2002:346: 1221-31.
12. Brunt EM, Janney CG, Di Bisceglie AM. Neuschwander-Tetri BA. Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999:94:2467-74.
13. Fan JG, Zhong L, Tia LY, Xu ZJ, Li MS, Wang GL. Effects of ursodeoxycholic acid and/or low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia. World J Gastroenterol 2005; 11:2346-50.
14. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
15. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998;114:842-5.
16. Chitturi S. Abeygunasekera S, Farrell GC. Holmes-Walker J, Hui JM. Fung C et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002;35:373-9.
17. Medina J, Fernandez-Salazar LI, Garcia-Buey L. Moreno-Otero R. Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care 2004;27:2057-66.
18. Chalasani N, Deeg MA, Persohn S, Crabb DW. Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2003;98:1849-55.
19. Fan JG, Zhong L, Xu ZJ, Tia LY, Ding XD, Li MS et al. Effects of lowcalorie diet on steatohepatitis in rats with obesity and hyperlipidemia. World J Gastroenterol 2003;9:2045-9.
20. Burt AD, MacSween R, Peters TJ. Non-alcoholic fatty liver: causes and complications. In: McIntyre N, editor. Oxford textbook of clinical hepatology. New York: Oxford University Press; 1991.p.865-71.
21. Gorski J, Oscai LB, Palmer WK. Hepatic lipid metabolism in exercise and training. Med Sci Sports Exerc 1990;22:213-21.
22. Terao T. Fujise T, Yamashita Y. Nakano S. Dependence of lipid-lipoprotein metabolism on exercise intensity in experimental fatty liver rats. Tokai J Exp Clin Med 1988;13:99-107.
23. Katsanos CS. Lipid-induced insulin resistance in the liver: role of exercise. Sports Med 2004;34:955-65.
24. Askew EW, Barakat H, Kuhl GL, Dohm GL. Response of lipogenesis and fatty acid synthetase to physical training and exhaustive exercise in rats. Lipids 1975;10:491-6.
25. Seki S, Kitada T, Yamada T, Sakaguchi H. Nakatani K, Wakasa K. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 2002;37:56-62.
26. Satapathy SK, Garg S, Chauhan R, Sakhuja P. Malhotra V, Sharma BC et al. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2004;99:1946-52.
27. Lieber CS, Leo MA, Mak KM, Xu Y, Cao Q. Ren C et al. Model of nonalcoholic steatohepatitis. Am J Clin Nutr 2004:79:502-9.